Total trials
117
Active
35
Phase 3
5
Total enrollment
13,682
Pipeline matrix
Showing 16 of 16 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| CD19 CAR-T cells | — | — | — | — | 2 | ||
| Cyclophosphamide | — | — | — | — | — | 1 | |
| Fludarabine | — | — | — | — | — | 1 | |
| Silver diamine fluoride- potassium iodide | — | — | — | — | — | 1 | |
| Fluoride varnish | — | — | — | — | — | 1 | |
| Gentamicin - single dose | — | — | — | — | — | 1 | |
| Distilled water | — | — | — | — | — | 1 | |
| CAR-T cells | — | — | — | — | — | 1 | |
| Autologous dentin graft | — | — | — | — | — | 1 | |
| Xenograft | — | — | — | — | — | 1 | |
| Hydroxychloroquine Oral | — | — | — | — | — | 1 | |
| Intrapleural t-PA/Dnase arm | — | — | — | — | — | 1 | |
| t-PA (Alteplase) 5-10mg and Tyloxapol 200mg | — | — | — | — | — | 1 | |
| Heparin saline lock | — | — | — | — | — | 1 | |
| Syrup Prospan | — | — | — | — | — | 1 | |
| N-Acetylcysteine | — | — | — | — | — | 1 |
Next readouts
- 2025-06-02
- 2026-06-01
- 2026-07-08
- 2026-08-31
- 2026-11-30
- 2027-01-18
- 2027-03-01
- 2027-11-30
- 2028-06-01
- 2028-12-02
Top conditions
- Gestational Diabetes3
- Pleural Effusion3
- Endophthalmitis Postoperative2
- Type 2 Diabetes2
- IVF2
- Trigger Finger2
- Rhinitis, Allergic2
- Choledocholithiasis2
Frequently asked questions about National University of Malaysia
- How many clinical trials does National University of Malaysia have on ClinicalTrials.gov?
- National University of Malaysia is listed as the lead sponsor on 117 clinical trials in ClinicalTrials.gov, 35 of which are currently active (recruiting, enrolling, or ongoing).
- How many of National University of Malaysia's trials are in Phase 3?
- 5 of National University of Malaysia's trials are in Phase 3, spread across 16 active drug programs.
- What therapeutic areas does National University of Malaysia focus on?
- National University of Malaysia's most-studied conditions on ClinicalTrials.gov are Gestational Diabetes, Pleural Effusion, Endophthalmitis Postoperative, Type 2 Diabetes, IVF.
- When are National University of Malaysia's next clinical trial readouts?
- National University of Malaysia has 10 upcoming primary-completion readouts tracked here; the soonest is “To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL)”, expected around 2025-06-02.